Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart Failure

PHASE2RecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 20, 2025

Primary Completion Date

November 1, 2027

Study Completion Date

January 1, 2028

Conditions
Acute Heart Failure (AHF)
Interventions
DIETARY_SUPPLEMENT

1,3-butanediol

1,3-butanediol (Ketone-IQ®) 118 mL (33 g) servings trice daily

DIETARY_SUPPLEMENT

Placebo

Taste-matched placebo (isovolumic, isoviscous water with stevia) 118 mL servings trice daily

Trial Locations (8)

5000

NOT_YET_RECRUITING

Department of Cardiology, Odense University Hospital, Odense

7400

RECRUITING

Department of Cardiology, Gødstrup Hospital, Herning, Denmark, Herning

8200

RECRUITING

Department of Cardiology, Aarhus University Hospital, Aarhus N

8800

RECRUITING

Department of Cardiology, Viborg Hospital, Viborg

Unknown

NOT_YET_RECRUITING

Department of Cardiology, Aalborg University Hospital, Aalborg

RECRUITING

Department of Cardiology, Herlev-Gentofte Hospital, Copenhagen

NOT_YET_RECRUITING

Department of Cardiology, Rigshospitalet, Copenhagen

RECRUITING

Department of Cardiology, Copenhagen University Hospital - Amager and Hvidovre Hospital, Hvidovre

All Listed Sponsors
collaborator

Viborg Regional Hospital

OTHER

collaborator

Hospitalsenhed Vest, Herning

UNKNOWN

collaborator

Odense University Hospital

OTHER

collaborator

Aalborg University Hospital

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Copenhagen University Hospital at Herlev

OTHER

collaborator

Copenhagen University Hospital, Amager-Hvidovre, Denmark

UNKNOWN

lead

Aarhus University Hospital

OTHER